Revenue
911 thousand USD
2022 Q4 · USD
Fundies. English
XINYINHAI TECHNOLOGY, LTD.
EDGAR47 filing records in this dataset, filed from 2004-11-15 to 2023-06-28. Reported financial figures are available; chart coverage varies by period.
Latest quarter
Operating margin
-91.2%
2022 Q4 · %
Operating cash flow
-578 thousand USD
2022 Q4 · USD
- Cash and cash equivalents
- 97.6 thousand USD Source
Exact value
97588 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 72.2 million shares Source
Exact value
72215933 shares
Reported share-count change
7.84% · 5.25 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Net income
-3.17 million USD
2022-01-01 – 2022-12-31
Exact inputs and evidence
Operating cash flow
-2.56 million USD
2022-01-01 – 2022-12-31
Exact inputs and evidence
- Operating cash flow: -565655 USD · 2022-01-01 – 2022-03-31 Source
- Operating cash flow: -1503273 USD · 2022-01-01 – 2022-06-30 Source
- Operating cash flow: -565655 USD · 2022-01-01 – 2022-03-31 Source
- Operating cash flow: -1985730 USD · 2022-01-01 – 2022-09-30 Source
- Operating cash flow: -1503273 USD · 2022-01-01 – 2022-06-30 Source
- Operating cash flow: -2564189 USD · 2022-01-01 – 2022-12-31 Source
- Operating cash flow: -1985730 USD · 2022-01-01 – 2022-09-30 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2023-06-28.
Financial data available through: 2022-12-31.
Coverage by financial measure
- Revenue: 3 of 11 periods available· newest 2022-12-31
- Operating income: 4 of 11 periods available· newest 2022-12-31
- Net income: 6 of 11 periods available· newest 2022-12-31
- Operating cash flow: 4 of 11 periods available· newest 2022-12-31
- capital expenditure: No compatible figures in this window
- Total assets: 3 of 11 periods available· newest 2022-12-31
- Total liabilities: 3 of 11 periods available· newest 2022-12-31
- Current assets: 3 of 11 periods available· newest 2022-12-31
- Current liabilities: 3 of 11 periods available· newest 2022-12-31
- Cash and cash equivalents: 3 of 11 periods available· newest 2022-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: 3 of 11 periods available· newest 2022-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+USD 1.69 millionPrior period
USD 0
–
Current period
USD 1.69 million
–
Exact inputs and evidence
1687691 − 0 = 1687691 USD
0 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source1687691 USD · 2022-01-01 – 2022-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 6.07 millionPrior period
−USD 9.11 million
–
Current period
−USD 3.04 million
–
Exact inputs and evidence
-3043585 − -9109218 = 6065633 USD
-9109218 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source-3043585 USD · 2022-01-01 – 2022-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 1.34 millionPrior period
−USD 1.22 million
–
Current period
−USD 2.56 million
–
Exact inputs and evidence
-2564189 − -1224798 = -1339391 USD
-1224798 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source-2564189 USD · 2022-01-01 – 2022-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2022 2022-01-01 – 2022-12-31
- Revenue USD 1.69 million 100% of revenue
- Cost of revenue USD 123,857 7.3% of revenue
- Operating expenses USD 5.02 million 298% of revenue
- Operating income −USD 3.46 million −205% of revenue
- Tax, interest and other Derived −USD 413,721 −25% of revenue
- Net income −USD 3.04 million −180% of revenue
Cash
- Operating cash flow −USD 2.56 million −152% of revenue
- Capital expenditure Unavailable An input is unavailable.
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2020 Not shown: operating income or net income is not reported.
- 2021 Not shown: operating income or net income is not reported.
- 2022 Operating loss: operating costs were 305% of revenue.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2020 2020-01-01 – 2020-12-31 | 0 | 709858 Derived | -709858 | 22350 Derived | -732208 | Unavailable | Source
|
| 2021 2021-01-01 – 2021-12-31 | 0 | 5005268 Derived | -5005268 | 4103950 Derived | -9109218 | Unavailable | Source
|
| 2022 2022-01-01 – 2022-12-31 | 1687691 | 5144997 Derived | -3457306 | -413721 Derived | -3043585 | Unavailable | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 1.7M 2022
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2020 | Revenue | 0 |
|
| 2021 | Revenue | 0 |
|
| 2022 | Revenue | 1687691 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Year over year | No prior comparable period |
|
| 2021 | Year over year | No prior comparable period |
|
| 2022 | Year over year | No prior comparable period |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin -204.9% 2022
Net margin -180.3% 2022
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Operating margin | Not reported |
|
| 2021 | Operating margin | Not reported |
|
| 2022 | Operating margin | -204.9% |
|
| 2020 | Net margin | Not reported |
|
| 2021 | Net margin | Not reported |
|
| 2022 | Net margin | -180.3% |
|
| 2020 | Free cash flow margin | Not reported |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD -2.6M 2022
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2020 | Operating cash flow | -637200 |
|
| 2021 | Operating cash flow | -1224798 |
|
| 2022 | Operating cash flow | -2564189 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2020 | Free cash flow | Unavailable |
|
| 2021 | Free cash flow | Unavailable |
|
| 2022 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
211.7% 2022
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Liabilities / assets | 441.1% |
|
| 2021 | Liabilities / assets | 253.1% |
|
| 2022 | Liabilities / assets | 211.7% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
0.42× 2022
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Current assets / current liabilities | 1.66× |
|
| 2021 | Current assets / current liabilities | 0.29× |
|
| 2022 | Current assets / current liabilities | 0.42× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2019 2018-07-01 – 2019-06-30 | −USD 5,365 Exact valueExact value: -5365 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2019 2019-01-01 – 2019-12-31 | −USD 548,668 Exact valueExact value: -548668 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 374,000 Exact valueExact value: -374000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2019-07-01 – 2020-06-30 | −USD 37,494 Exact valueExact value: -37494 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2020 2020-01-01 – 2020-12-31 | −USD 732,208 Exact valueExact value: -732208 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 637,200 Exact valueExact value: -637200 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | −USD 9.11 million Exact valueExact value: -9109218 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.22 million Exact valueExact value: -1224798 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | −USD 3.04 million Exact valueExact value: -3043585 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.56 million Exact valueExact value: -2564189 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
47 filings · 883 latest values · 883 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001307624, 1307624, edgar:1307624
Also known as HEALTHTECH SOLUTIONS, INC./UT, HYB Holding Corp., Healthtech Solutions, Inc./UT, IRON STAR DEVELOPMENT, INC., XINYINHAI TECHNOLOGY, LTD.